Helsinn Therapeutics (U.S.), Inc. was founded in 2009 and is based in New Jersey, USA. It was founded through the acquisition of a small R&D-focused company, and over the years has evolved into an integrated specialty pharmaceutical company focused on oncology including dermatological presentations.
Since 2013, we’ve deployed a specialty sales force, a market access team and a field medical team responsible for the direct commercialization of Aloxi®, Akynzeo® (oral and i.v.), Valchlor® and other products.
In addition, we have participated in several co-promotions for oncology therapeutics. As Helsinn Therapeutics (U.S.), Inc. continues to evolve, we remain committed to improving care for patients through our work to commercialize cancer therapeutics and cancer supportive care agents.
Helsinn Therapeutics (U.S.), Inc.
200 Wood Avenue South, Suite 100
Iselin, NJ 08830
Tel: +1 732 603 2800
Fax: +1 732 744 1088